Serum alpha and beta-CGRP levels in chronic migraine patients before and after monoclonal antibodies against CGRP or its receptor.
Authors
Gárate G, González-Quintanilla V, González A, Pascual M, Pérez-Pereda S, Madera J, Pascual J
Abstract
To analyse the evolution of alpha and beta-CGRP circulating levels throughout CGRP monoclonal antibodies (mAb) treatment in chronic migraine (CM) patients.
